Vanda Pharmaceuticals buy Cantor Fitzgerald
Start price
14.05.25
/
50%
€3.56
Target price
14.05.26
€11.62
Performance (%)
91.01%
Price
21.01.26
€6.80
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald for Vanda Pharmaceuticals has seen massive gains of 91.01%. This prediction currently runs until 14.05.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vanda Pharmaceuticals | 3.125% | 3.125% |
| iShares Core DAX® | -3.141% | 1.269% |
| iShares Nasdaq 100 | -3.518% | -1.355% |
| iShares Nikkei 225® | -3.396% | 3.283% |
| iShares S&P 500 | -2.943% | -0.533% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $13.00 price target on the stock.
Ratings data for VNDA provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Vanda Pharmaceuticals
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€3.82
30.10.25
30.10.25
€9.47
30.10.26
30.10.26
78.01%
21.01.26
21.01.26
Vanda Pharmaceuticals
Start price
Target price
Perf. (%)
€5.25
01.08.24
01.08.24
€12.05
01.08.25
01.08.25
-31.81%
02.08.25
02.08.25

